REDCARE PHARMACY NV (RDC.DE) Stock Analyst Earnings Estimates
FRA:RDC - Deutsche Boerse Ag - NL0012044747 - Common Stock - Currency: EUR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.204B 13.59% | 1.799B 49.35% | 2.371B 31.79% | 3.012B 27.06% | 3.645B 21.02% | 4.334B 18.90% | 4.863B 12.21% | 5.551B 14.15% | 5.903B 6.34% | 6.372B 7.95% | 6.725B 5.54% | |
| EBITDA YoY % growth | -13.99M 64.07% | 49.669M 455.03% | 29.778M -40.05% | 65.181M 118.89% | 128.38M 96.96% | 188.81M 47.07% | 275.38M 45.85% | 357.99M 30.00% | N/A | N/A | N/A | |
| EBIT YoY % growth | -53.5M 18.82% | -7.619M 85.76% | -38.439M -404.52% | -13.882M 63.89% | 54.99M 496.13% | 101.23M 84.09% | 209.46M 106.91% | 229.94M 9.78% | 265.93M 15.65% | N/A | N/A | |
| Operating Margin | -4.44% | -0.42% | -1.62% | -0.46% | 1.51% | 2.34% | 4.31% | 4.14% | 4.50% | N/A | N/A | |
| EPS YoY % growth | N/A -46.28% | N/A 74.56% | N/A -91.90% | -1.10 42.87% | 1.41 228.20% | 3.54 151.09% | 7.73 118.12% | 12.39 60.32% | N/A | N/A | N/A |
All data in EUR
| Q2 / 25 | Q3 / 25 | |
|---|---|---|
| EPS Q2Q % growth | -0.22 -2.44% | -0.25 29.30% |
| Revenue Q2Q % growth | 717.28M 27.93% | 731.64M 27.34% |
| EBITDA Q2Q % growth | 13.13M -56.93% | 18.736M -57.40% |
| EBIT Q2Q % growth | N/A | N/A |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.53 | -0.72 | 0.19 | 26.81% |
| Q4 2024 Q2Q % growth | -1.32 | -0.93 | -0.39 | -42.68% |
| Q3 2024 Q2Q % growth | -0.35 | -0.66 | 0.31 | 47.25% |
| Q2 2024 Q2Q % growth | -0.21 | -0.08 | -0.13 | -159.90% |
| Q4 2021 Q2Q % growth | -2.46 | -1.29 | -1.17 | -90.28% |
| Q3 2021 Q2Q % growth | -0.79 | -0.49 | -0.30 | -59.63% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 717.286M 28.04% | 722.84M | -5.554M | -0.77% |
| Q4 2024 Q2Q % growth | 675.137M 27.07% | 690.64M | -15.503M | -2.24% |
| Q3 2024 Q2Q % growth | 574.548M 20.83% | 581.98M | -7.432M | -1.28% |
| Q2 2024 Q2Q % growth | 560.674M 33.53% | 380.37M | 180.304M | 47.40% |
| Q1 2024 Q2Q % growth | 560.216M 50.56% | % | ||
| Q4 2023 Q2Q % growth | 531.318M 62.09% | % | ||
| Q3 2023 Q2Q % growth | 475.5M 67.14% | % | ||
| Q2 2023 Q2Q % growth | 419.9M 46.20% | % | ||
| Q1 2023 Q2Q % growth | 372.1M 22.08% | % | ||
| Q4 2022 Q2Q % growth | 327.8M 13.82% | % | ||
| Q3 2022 Q2Q % growth | 284.5M 19.59% | % | ||
| Q2 2022 Q2Q % growth | 287.2M 14.70% | % | ||
| Q1 2022 Q2Q % growth | 304.8M 7.29% | % | ||
| Q4 2021 Q2Q % growth | 288M 8.80% | 293.18M | -5.18M | -1.77% |
| Q3 2021 Q2Q % growth | 237.9M -0.34% | 248.93M | -11.03M | -4.43% |
| Q2 2021 Q2Q % growth | 250.4M 7.61% | % | ||
| Q1 2021 Q2Q % growth | 284.1M 22.46% | % | ||
| Q4 2020 Q2Q % growth | 264.7M 37.94% | % | ||
| Q3 2020 Q2Q % growth | 238.7M 39.67% | % | ||
| Q2 2020 Q2Q % growth | 232.7M 42.24% | % | ||
| Q1 2020 Q2Q % growth | 232M 32.88% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 1.39% | 0% | 0% |
| Revenue | 0.07% | 0.17% | 0% | -0.4% |